Janus Henderson Group PLC Dyne Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,813,163 shares of DYN stock, worth $204 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
6,813,163
Previous 4,623,824
47.35%
Holding current value
$204 Million
Previous $163 Million
49.98%
% of portfolio
0.13%
Previous 0.09%
Shares
16 transactions
Others Institutions Holding DYN
# of Institutions
210Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$241 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$222 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$206 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$204 Million3.9% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$191 Million3.2% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.55B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...